Show Summary Details
Page of

Treatment-induced complications 

Treatment-induced complications
Chapter:
Treatment-induced complications
Author(s):

James Harvey

, Sue Down

, Rachel Bright-Thomas

, John Winstanley

, and Hugh Bishop

DOI:
10.1093/med/9780199215065.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 August 2019

Treatment induced complications. Complications following any treatment for breast cancer are important, as, aside from the obvious immediate problems, any complication can delay further treatment, thus potentially compromising prognosis and mortality. This chapter covers in some detail potential problems arising following surgery, radiotherapy and systemic therapy. Risk factors for surgical complications are expounded, and post-operative sequelae are described as immediate, early and late problems. This is essential knowledge when consenting patients for surgery, but also invaluable for those whom the patient consults regarding surgical options prior to making a final decision. Similarly, the side effects of radiotherapy, hormonal manipulation, chemotherapy and biological therapies should be recognised early, and appropriate action taken to minimise morbidity and reduce any delay in further adjuvant treatment.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.